Velocity Clinical Research - Norfolk

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Diabetic neuropathy2 trials
• Migraine1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials

Lead sponsor

• Vertex Pharmaceuticals Incorporated2 trials
• Currax Pharmaceuticals1 trial
• Housey Healthcare ULC1 trial
• ModernaTX, Inc.1 trial
• TriGemX Bio, Inc.1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Charles Harper

• Active, not recruiting

  Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

  NCT06696443· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

  NCT06628908· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

• Recruiting

  HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  NCT07546929· Phase 2· Housey Healthcare ULC· Source

  Contact: Charles Harper, MD (principal investigator)

• Active, not recruiting

  A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

  NCT05164094· Phase 1/2· ModernaTX, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic neuropathy1 recruiting
• Migraine1 recruiting
• Type 2 diabetes1 recruiting